Abstract: The present application provides methods for editing RNA by introducing a deaminase-recruiting RNA in a host cell for deamination of an adenosine in a target RNA. The present application further provides deaminase-recruiting RNAs used in the RNA editing methods and compositions comprising the same.
Type:
Grant
Filed:
October 14, 2021
Date of Patent:
July 18, 2023
Assignees:
EDIGENE THERAPEUTICS (BEIJING) INC., PEKING UNIVERSITY